Therefore, the inhibition of glutamine uptake by the glutamine transporter (ASCT2), as well as the inhibition of glutaminase, GDH, GOT1 and GPT2, seem to all be good strategies to decrease the replenishment of intermediates in the TCA cycle and, consequently, cancer cell proliferation. The gene discussed is GOT1; the disease is cancer.